1. Home
  2. OPK vs MLTX Comparison

OPK vs MLTX Comparison

Compare OPK & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

N/A

Current Price

$1.59

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

N/A

Current Price

$11.17

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPK
MLTX
Founded
2006
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
OPK
MLTX
Price
$1.59
$11.17
Analyst Decision
Buy
Buy
Analyst Count
6
16
Target Price
$4.15
★ $30.29
AVG Volume (30 Days)
★ 2.9M
1.5M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $606,879,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$9.46
52 Week High
$1.86
$23.29

Technical Indicators

Market Signals
Indicator
OPK
MLTX
Relative Strength Index (RSI) 42.81 44.69
Support Level $1.46 $10.67
Resistance Level $1.58 $13.64
Average True Range (ATR) 0.09 0.83
MACD -0.02 -0.12
Stochastic Oscillator 9.52 14.06

Price Performance

Historical Comparison
OPK
MLTX

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: